Stay updated on Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.5 is now shown, indicating a site update; study details and navigation remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-05T09:15:45.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    New page revision v3.5.4 was published, replacing the prior v3.5.3. This marks a minor update to the page version, with no apparent changes to the study content.
    Difference
    0.1%
    Check dated 2026-05-15T07:40:35.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page’s displayed release/revision version from v3.5.2 to v3.5.3 without changing the study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:21:52.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:35:59.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T21:52:03.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added revision: v3.4.3. Deleted revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T18:20:39.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.